Fabhalta Bridge Program

Funded
About
The Fabhalta Bridge Program offers significant benefits for patients prescribed Fabhalta, particularly those experiencing delays in insurance coverage. By providing up to 12 months of Fabhalta doses, the Fabhalta Bridge Program ensures continuous access to treatment while awaiting insurance approval. Leveraging the Fabhalta Bridge Program can greatly assist in maintaining treatment regimens without interruption.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Benefits
12 maximum fills per year
Program Requirements
Enrollment Required: Yes
Coverage Required: No
Needs Based: No
Activation Required: No
Program Details
Eligible patients facing a delay in insurance coverage may be able to receive a monthly maintenance dose for up to 12 months or until insurance coverage approval, whichever occurs first
HCP should submit completed enrollment form via fax to: 8774432242
For assistance or additional information, call 8339932242
Other Programs
Assistance Fund: Immunoglobulin A Nephropathy (IgAN)
Fabhalta at no costSee program details for eligibility
Assistance Fund: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Fabhalta at no costSee program details for eligibility
Other Tools for Fabhalta